Across England, a striking inversion has emerged in the geography of disability claims: it is the prosperous towns, not the struggling ones, where young people are most rapidly gaining recognition and support for ADHD and autism. Since the pandemic, the architecture of diagnosis — long NHS queues, costly private shortcuts, and a labyrinthine claims process — has quietly sorted access by wealth, raising a question as old as public medicine itself: does a system designed for all serve those who need it most?
Affluent areas see fastest growth in young people's ADHD and autism disability claims
Young people with ADHD and autism in deprived areas face delayed diagnoses and reduced access to disability support compared to affluent peers, perpetuating health inequality.
Those with better resources reach the front of the queue faster
Mark
So the story here is that rich areas are seeing faster growth in ADHD and autism disability claims than poor areas. That seems backwards.
Mimi
It does, because usually disability benefits cluster in deprived areas. But the researchers say it's not about who actually has ADHD or autism—it's about who can get diagnosed quickly.
Mark
And that's a money thing.
Mimi
Exactly. Wealthier families pay for private diagnoses to skip NHS waiting lists. Once you have a diagnosis, your Pip claim is much more likely to succeed.
Luke
But we should be careful here. The research shows the pattern in claims, not in actual prevalence of the conditions. We don't know if more affluent kids actually have ADHD and autism at higher rates, or if they're just better at getting diagnosed and claiming.
Mimi
Right. The researchers themselves say this is about access to diagnosis, not about the conditions being more common in rich areas.
Mark
What about the numbers? How big is this shift?
Mimi
Surrey Heath saw a 630 percent increase in claims since 2019. Blackpool saw 30 percent. That's a massive gap.
Luke
And the total cost is £1.36 billion a year for 205,000 young people. That's real money, and it's growing fast.
Mark
Is anyone saying this is a problem that needs fixing?
Mimi
The government commissioned a review. They're looking at a "needs-based" system that would prioritize people most acutely affected—those at risk of self-harm or unable to work.
Luke
Which could mean fewer people get diagnosed and supported, depending on how it's designed. That's the tension nobody's quite naming yet.
The Pulse
- Surrey Heath recorded a 630% surge in ADHD and autism disability claims since 2019, while economically deprived Blackpool managed just 30% — a reversal that exposes how wealth, not need, is driving access.
- Wealthier families are bypassing NHS waiting lists through private diagnoses costing hundreds of pounds, then leveraging that paperwork to navigate a Pip claims process that routinely defeats those without support.
- The pattern is specific to neurodivergent conditions — depression, anxiety, and physical disabilities show no similar geographic skew — pointing to a structural flaw in how these diagnoses are gatekept rather than any difference in prevalence.
- A racial dimension compounds the inequality: Pip claims for ADHD and autism are disproportionately low in ethnically diverse urban areas, mirroring wider disparities in mental health recognition and treatment.
- A government-commissioned review may recommend a needs-based triage system, but without addressing the private diagnosis shortcut, reform risks entrenching the very inequalities it seeks to correct.
Across England, a striking inversion has emerged in the geography of disability claims: it is the prosperous towns, not the struggling ones, where young people are most rapidly gaining recognition and support for ADHD and autism. Since the pandemic, the architecture of diagnosis — long NHS queues, costly private shortcuts, and a labyrinthine claims process — has quietly sorted access by wealth, raising a question as old as public medicine itself: does a system designed for all serve those who need it most?
In Surrey Heath, one of England's more comfortable corners, disability benefit claims for ADHD and autism have risen by 630 percent since 2019. In Blackpool, a town shaped by decades of economic hardship, the same figure is 30 percent. That contrast — affluence outpacing deprivation in a domain where the reverse has long been the norm — is what researchers at the Nuffield Trust say reveals something fundamental about how access, not illness, is driving the numbers.
By April 2026, around 205,000 young people aged 16 to 24 were receiving the personal independence payment for neurodivergent conditions, more than triple the 2019 figure. The annual bill reached £1.36 billion. Yet the sharpest growth came not from the poorest postcodes but from places like Wokingham, Warwick, and parts of Hampshire — areas of high income and strong educational attainment.
The explanation, as senior policy analyst Sally Gainsbury frames it, is straightforward: wealthier families can afford private diagnoses, bypassing NHS waiting lists that stretch for years. A clinical diagnosis dramatically improves the odds of a successful Pip claim, and families with resources are also better equipped to navigate an application process notorious for its opacity. GP records confirm the pattern — new ADHD diagnoses are appearing at higher rates in relatively affluent areas than in deprived ones.
The trend is peculiar to neurodivergent conditions. No comparable geographic skew appears in claims for depression, anxiety, learning disabilities, or physical conditions, suggesting the gap reflects the structure of diagnosis and benefit access rather than any difference in how these conditions are distributed across the population. A racial dimension compounds the picture: claims are lower than expected in ethnically diverse areas such as Newham, Brent, and Leicester, echoing broader inequalities in mental health recognition.
The surge has become politically charged, with some questioning whether rising claims reflect genuine need or overdiagnosis. A government-commissioned review led by clinical psychologist Prof Peter Fonagy has already found that the current system compels people to obtain a formal diagnosis simply to access any support. Its full recommendations are expected to propose a needs-based model prioritising those most acutely affected — but whether such a reform can close the gap between those who can afford a private diagnosis and those who cannot remains the central, unresolved question.
In Surrey Heath, a prosperous corner of southern England, claims for disability benefits related to ADHD and autism have surged by 630 percent since 2019. In Blackpool and Stoke-on-Trent, towns marked by economic hardship, the same claims rose by 30 and 50 percent respectively. This reversal of the usual pattern—where disability benefit claims cluster in poorer areas—points to something researchers at the Nuffield Trust say is fundamentally about access and money.
The data is stark. About 205,000 young people aged 16 to 24 received the personal independence payment, or Pip, for ADHD and autism-related disabilities in April 2026, more than triple the number in 2019. The annual cost hit £1.36 billion in 2025-26, with the average claimant receiving £8,800 per year. Yet the geographic pattern tells a story that defies expectation. The sharpest growth has come not from the poorest postcodes but from affluent districts like Wokingham, Warwick, and parts of Hampshire and Surrey—places where household incomes are highest and educational attainment strongest.
Sally Gainsbury, a senior policy analyst at the Nuffield Trust, frames the explanation plainly: wealthier families can afford to sidestep the NHS waiting lists by paying for private diagnoses. A clinical diagnosis, once obtained, substantially improves the odds of a successful Pip claim. Families with resources can also navigate the notoriously opaque and unpredictable Pip application process more effectively. The result is what Gainsbury calls "substantial inequality in access"—those with better resources and more support reach the front of the queue faster. GP records confirm this pattern: new ADHD diagnoses are being recorded at higher rates in relatively affluent areas than in deprived ones.
The trend is peculiar to neurodivergent conditions. Researchers found no similar pattern in learning disability, depression, anxiety, or physical conditions. This specificity suggests the gap is not about disease prevalence but about the architecture of diagnosis and benefit claims. While Pip is designed to help with the extra costs of disability—energy bills, transport, food—and is not means-tested or tied to employment, access to the diagnosis that unlocks it remains unequal.
The racial dimension adds another layer. Pip claims for ADHD and autism are higher among white people than other ethnic groups, a disparity reflected in lower-than-expected claims in ethnically diverse areas like Newham and Brent in London, and Leicester. The researchers do not speculate on causes, but the pattern mirrors broader inequalities in mental health diagnosis and treatment.
This surge in claims has become a flashpoint in British politics. Right-wing media and politicians have questioned whether the rise reflects genuine need or exaggerated symptoms and overdiagnosis. The government has commissioned a review led by Prof Peter Fonagy, a clinical psychologist at University College London, to examine the system. An interim report published earlier this year found that the current structure forces children and adults to obtain a formal diagnosis simply to access any support at all. The full review is expected to recommend a "needs-based" system in which stretched NHS services prioritize patients most acutely affected—those at risk of self-harm or unable to work.
The broader context is one of rising disability benefit spending. Working-age disability benefits are forecast to climb from £14 billion in 2019 to £34 billion in 2030. Young people claiming Pip and other disability benefits have increased sharply, particularly since the pandemic. The question now is whether the system can be reformed to match resources to need without widening the gap between those who can afford a private diagnosis and those who cannot.
Notable Quotes
Substantial inequality in access to private and NHS diagnostic services, meaning people with better resources and more support are often able to get to the front of the queue quicker— Sally Gainsbury, senior policy analyst at the Nuffield Trust
Want the full story?
Read the original at The Guardian ↗
Science & Space